3DBioFibR Inc.: federal grants and contributions: 20 agreements; $3.7M value; 2 departments; 8 programs.
Assay record ASY-CA-0067XDG18Z · Cite as: Assay Systems, “3DBioFibR Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/3dbiofibr-inc/
Adaptation of 3D BioFibR’s contact drawn collagen manufacturing system to build and refine 2D and 3D tissue culture and artificial tendons products for the medical research community.
Support scale-up of manufacturing and research facility
Development of 3D BioFibR’s automated collagen fiber manufacturing system to increase the mechanical durability and physiological relevance of 3D tissue models for the medical research community.
Support manufacturing automation, scale-up and ISO readiness for commercial expansion
Support manufacturing scale-up and ISO certification for clinical applications
As part of Multinational Corporate Collaboration Program, the project CIBI will focus on integration and co-development of 3DBF’s collagen fiber (CollaFibR™) technology with the cell culture insert from an international partner, to create a novel, highly consistent, and physiologically relevant 3D cell culture product for the medical research community.
Scale up automation of protein fiber manufacturing
Support launch activities for manufacturing high-value biofibers
Integration and co-development of collagen fiber (CollaFibR™) technology with the cell culture insert from an international partner, to create a novel, highly consistent, and physiologically relevant 3D cell culture product for the medical research community.
Engage consultant for strategic business consulting and technology development
Engage expertise to improve organizational efficiency and productivity
Engage expertise to conduct market research to validate market verticals
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Engage expertise for strategic partnership development
The Project will support development of intellectual property capacity within the Firm.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The Project will support development of intellectual property capacity within the Firm.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Participation in the Canadian medical biotechnology co-innovation mission to the Eureka Global Innovation Summit and Swiss Biotech Day in Switzerland. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop international partnerships and potential project ideas under the Eureka Programs.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.